Literature DB >> 11096705

Brain Abscess.

.   

Abstract

Optimal treatment of a brain abscess requires early clinical suspicion, and the diagnosis is usually made by identification of the abscess on contrast-enhanced computed tomography (CT) or magnetic resonance imaging (MRI). The immediate first step is to reduce the potentially life-threatening brain mass (abscess and surrounding cerebral edema) and secure the diagnosis with culture specimens. This is usually accomplished by reducing the increased intracranial pressure (ICP) through surgical aspiration with or without drainage of the abscess pus. The surgical procedure chosen depends on several factors, including the location and type of abscess, multiplicity, and the medical condition of the patient. In addition, dexamethasone and hyperventilation may be required if brain herniation is imminent. The dexamethasone dose should be reduced as soon as the ICP is reduced because steroid administration may retard abscess capsule formation and decrease antibiotic concentrations within the abscess cavity. Antibiotic therapy should be started as soon as the diagnosis is made. Penicillin G or third-generation cephalosporins plus metronidazole are commonly given to treat both anaerobic and aerobic bacteria. The initial choice of antibiotic will vary on the basis of the suspected source of the brain organisms, which is most often either contiguous spread from a sinus or mastoid infection or hematogenous spread from a pulmonary, gastrointestinal, cardiac, or dental infection. Isolation and determination of the antibiotic sensitivities of the organism from abscess pus allow definitive antibiotic therapy. Patients should be managed in an intensive care unit. Phenytoin is often given to prevent seizures, which could further elevate the ICP. The duration of antimicrobial treatment is 4 to 8 weeks, during which time the patient should be monitored clinically and with repeated neuroimaging studies to ensure abscess resolution.

Entities:  

Year:  1999        PMID: 11096705     DOI: 10.1007/s11940-999-0015-7

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  29 in total

1.  Role of in vivo proton magnetic resonance spectroscopy in the diagnosis and management of brain abscesses.

Authors:  R Dev; R K Gupta; H Poptani; R Roy; S Sharma; M Husain
Journal:  Neurosurgery       Date:  1998-01       Impact factor: 4.654

2.  Diagnostic and staged stereotactic aspiration of multiple bihemispheric pyogenic brain abscesses.

Authors:  A G Chacko; M J Chandy
Journal:  Surg Neurol       Date:  1997-09

3.  Brain abscesses in neonates. A study of 30 cases.

Authors:  D Renier; C Flandin; E Hirsch; J F Hirsch
Journal:  J Neurosurg       Date:  1988-12       Impact factor: 5.115

4.  Brain abscesses in children--a cooperative study of 83 cases.

Authors:  T T Wong; L S Lee; H S Wang; E Y Shen; W C Jaw; C H Chiang; C S Chi; K L Hung; W Y Liou; Y Z Shen
Journal:  Childs Nerv Syst       Date:  1989-02       Impact factor: 1.475

5.  Improved management of multiple brain abscesses: a combined surgical and medical approach.

Authors:  A N Mamelak; T J Mampalam; W G Obana; M L Rosenblum
Journal:  Neurosurgery       Date:  1995-01       Impact factor: 4.654

Review 6.  Bacterial brain abscesses: factors influencing mortality and sequelae.

Authors:  C Seydoux; P Francioli
Journal:  Clin Infect Dis       Date:  1992-09       Impact factor: 9.079

7.  Clinical stages of human brain abscesses on serial CT scans after contrast infusion. Computerized tomographic, neuropathological, and clinical correlations.

Authors:  R H Britt; D R Enzmann
Journal:  J Neurosurg       Date:  1983-12       Impact factor: 5.115

Review 8.  Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects.

Authors:  L E Davis; M Kornfeld
Journal:  Eur Neurol       Date:  1991       Impact factor: 1.710

9.  Incidence and prognosis of brain abscess in a defined population: Olmsted County, Minnesota, 1935-1981.

Authors:  A Nicolosi; W A Hauser; M Musicco; L T Kurland
Journal:  Neuroepidemiology       Date:  1991       Impact factor: 3.282

Review 10.  Clindamycin and metronidazole.

Authors:  M E Falagas; S L Gorbach
Journal:  Med Clin North Am       Date:  1995-07       Impact factor: 5.456

View more
  4 in total

1.  Roles of Toll-like receptor 2 (TLR2) and superantigens on adaptive immune responses during CNS staphylococcal infection.

Authors:  Debbie Vidlak; Monica M Mariani; Amy Aldrich; Shuliang Liu; Tammy Kielian
Journal:  Brain Behav Immun       Date:  2010-09-22       Impact factor: 7.217

2.  Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection.

Authors:  Monica M Holley; Tammy Kielian
Journal:  J Immunol       Date:  2011-12-21       Impact factor: 5.422

3.  The synthetic peroxisome proliferator-activated receptor-gamma agonist ciglitazone attenuates neuroinflammation and accelerates encapsulation in bacterial brain abscesses.

Authors:  Tammy Kielian; Mohsin Md Syed; Shuliang Liu; Nirmal K Phulwani; Napoleon Phillips; Gail Wagoner; Paul D Drew; Nilufer Esen
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

4.  Differential effects of interleukin-17 receptor signaling on innate and adaptive immunity during central nervous system bacterial infection.

Authors:  Debbie Vidlak; Tammy Kielian
Journal:  J Neuroinflammation       Date:  2012-06-15       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.